BIONET Corp.
TWO: 1784.TWO0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Taipei Exchange
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- CEO
- Qing Yuan Kang
- Headquarters
- Taipei, Taiwan
- IPO year
- 2007
- Market cap
- NT$3.7B
- Website
- https://www.bionetcorp.com
Loading 1784…
Loading profile data…Frequently asked questions about 1784
What does BIONET Corp. (1784.TWO) do?
BIONET Corp. provides cord blood banking services in Taiwan and internationally. The company offers stem cell banking services, including stem cell storage, mesenchymal stem cell storage, dental stem cell storage, adipose stem cell, and PBSC + immune cells; and genetic testing services. It also provides stem anti-aging and ANIKINE series product...
Where does 1784.TWO trade?
BIONET Corp. (1784.TWO) trades on the Taipei Exchange.
What sector is 1784.TWO in?
BIONET Corp. (1784.TWO) operates in the Healthcare sector, specifically in the Medical - Diagnostics & Research industry.
Who is the CEO of BIONET Corp.?
Qing Yuan Kang is the chief executive officer of BIONET Corp. (1784.TWO).
Where is BIONET Corp. headquartered?
BIONET Corp. is headquartered in Taiwan.
Does 1784.TWO pay a dividend?
Yes — BIONET Corp. (1784.TWO) paid a trailing twelve-month dividend of TWD 1.42 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did 1784.TWO go public?
BIONET Corp. (1784.TWO) completed its initial public offering in 2007.